BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30287485)

  • 1. Integrative genomic analysis of mouse and human hepatocellular carcinoma.
    Dow M; Pyke RM; Tsui BY; Alexandrov LB; Nakagawa H; Taniguchi K; Seki E; Harismendy O; Shalapour S; Karin M; Carter H; Font-Burgada J
    Proc Natl Acad Sci U S A; 2018 Oct; 115(42):E9879-E9888. PubMed ID: 30287485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.
    Moeini A; Torrecilla S; Tovar V; Montironi C; Andreu-Oller C; Peix J; Higuera M; Pfister D; Ramadori P; Pinyol R; Solé M; Heikenwälder M; Friedman SL; Sia D; Llovet JM
    Gastroenterology; 2019 Nov; 157(5):1383-1397.e11. PubMed ID: 31344396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of HCC Mouse Models: Towards an Etiology-Oriented Subtyping Approach.
    Friemel J; Frick L; Unger K; Egger M; Parrotta R; Böge YT; Adili A; Karin M; Luedde T; Heikenwalder M; Weber A
    Mol Cancer Res; 2019 Jul; 17(7):1493-1502. PubMed ID: 30967480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Genomic Comparison of Mouse Models Reveals Their Clinical Resemblance to Human Liver Cancer.
    Yim SY; Shim JJ; Shin JH; Jeong YS; Kang SH; Kim SB; Eun YG; Lee DJ; Conner EA; Factor VM; Moore DD; Johnson RL; Thorgeirsson SS; Lee JS
    Mol Cancer Res; 2018 Nov; 16(11):1713-1723. PubMed ID: 30082483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational landscape of a chemically-induced mouse model of liver cancer.
    Connor F; Rayner TF; Aitken SJ; Feig C; Lukk M; Santoyo-Lopez J; Odom DT
    J Hepatol; 2018 Oct; 69(4):840-850. PubMed ID: 29958939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of hepatocarcinogenesis using mouse models.
    Teoh WW; Xie M; Vijayaraghavan A; Yaligar J; Tong WM; Goh LK; Sabapathy K
    Dis Model Mech; 2015 Jul; 8(7):743-53. PubMed ID: 26035378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
    Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
    J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma.
    Khan MGM; Ghosh A; Variya B; Santharam MA; Ihsan AU; Ramanathan S; Ilangumaran S
    BMC Cancer; 2020 Aug; 20(1):774. PubMed ID: 32807134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features.
    Zhu C; Ho YJ; Salomao MA; Dapito DH; Bartolome A; Schwabe RF; Lee JS; Lowe SW; Pajvani UB
    J Hepatol; 2021 Mar; 74(3):613-626. PubMed ID: 33038431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A signature of six genes highlights defects on cell growth and specific metabolic pathways in murine and human hepatocellular carcinoma.
    Schröder PC; Segura V; Riezu JI; Sangro B; Mato JM; Prieto J; Santamaría E; Corrales FJ
    Funct Integr Genomics; 2011 Sep; 11(3):419-29. PubMed ID: 21562899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive molecular and immunological characterization of hepatocellular carcinoma.
    Shimada S; Mogushi K; Akiyama Y; Furuyama T; Watanabe S; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Arii S; Tanabe M; Wands JR; Tanaka S
    EBioMedicine; 2019 Feb; 40():457-470. PubMed ID: 30598371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of bone marrow-derived cells in the origin of liver cancer revealed by single-cell sequencing.
    Chen L; Yi X; Guo P; Guo H; Chen Z; Hou C; Qi L; Wang Y; Li C; Liu P; Liu Y; Xu Y; Zhang N
    Cancer Biol Med; 2020 Feb; 17(1):142-153. PubMed ID: 32296582
    [No Abstract]   [Full Text] [Related]  

  • 13. Genomic Analysis of Vascular Invasion in HCC Reveals Molecular Drivers and Predictive Biomarkers.
    Krishnan MS; Rajan Kd A; Park J; Arjunan V; Garcia Marques FJ; Bermudez A; Girvan OA; Hoang NS; Yin J; Nguyen MH; Kothary N; Pitteri S; Felsher DW; Dhanasekaran R
    Hepatology; 2021 Jun; 73(6):2342-2360. PubMed ID: 33140851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma.
    Shen J; Tsoi H; Liang Q; Chu ES; Liu D; Yu AC; Chan TF; Li X; Sung JJ; Wong VW; Yu J
    Oncogene; 2016 Dec; 35(49):6271-6280. PubMed ID: 27132506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical implications of G1-G6 transcriptomic signature and 5-gene score in Korean patients with hepatocellular carcinoma.
    Ahn SM; Haq F; Park I; Nault JC; Zucman-Rossi J; Yu E
    BMC Cancer; 2018 May; 18(1):571. PubMed ID: 29776391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma.
    Joseph NM; Tsokos CG; Umetsu SE; Shain AH; Kelley RK; Onodera C; Bowman S; Talevich E; Ferrell LD; Kakar S; Krings G
    J Pathol; 2019 Jun; 248(2):164-178. PubMed ID: 30690729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse models of hepatocellular carcinoma.
    Fausto N; Campbell JS
    Semin Liver Dis; 2010 Feb; 30(1):87-98. PubMed ID: 20175036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative and comparative genomics analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and old.
    Colak D; Chishti MA; Al-Bakheet AB; Al-Qahtani A; Shoukri MM; Goyns MH; Ozand PT; Quackenbush J; Park BH; Kaya N
    Mol Cancer; 2010 Jun; 9():146. PubMed ID: 20540791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
    Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
    Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcript profiling identifies iqgap2(-/-) mouse as a model for advanced human hepatocellular carcinoma.
    Gnatenko DV; Xu X; Zhu W; Schmidt VA
    PLoS One; 2013; 8(8):e71826. PubMed ID: 23951254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.